Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 174,055 | 174,350 | 167,204 | 158,805 | 154,994 |
| Cost of Goods | 38,929 | 42,157 | 44,729 | 41,472 | 38,521 |
| Gross Profit | 135,126 | 132,193 | 122,475 | 117,333 | 116,473 |
| Operating Expenses | 203,475 | 172,743 | 159,225 | 157,326 | 154,859 |
| Operating Income | -67,420 | -40,393 | -36,021 | -39,521 | -37,865 |
| Interest Expense | 1,838 | 561 | -5,999 | -4,542 | -7,570 |
| Pre-tax Income | -69,258 | -40,954 | -30,022 | -34,979 | -30,295 |
| Income Tax | 1,880 | -16,455 | 7,248 | 5,160 | 4,024 |
| Net Income Continuous | -71,138 | -24,499 | -37,270 | -40,139 | -34,319 |
| Net Income | $-71,138 | $-24,499 | $-37,270 | $-40,139 | $-34,319 |
| EPS Basic Total Ops | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 |
| EPS Basic Continuous Ops | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 |
| EPS Diluted Total Ops | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 |
| EPS Diluted Continuous Ops | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.62 | -0.22 | -0.33 | -0.36 | -0.31 |
| EBITDA(a) | $-65,913 | $-39,921 | $-38,760 | $-42,537 | $-41,194 |